Philippe R. Marteau

Philippe R. Marteau's AcademicInfluence.com Rankings

Philippe R. Marteau

Biology

#12967

World Rank

#16478

Historical Rank

Microbiology

#790

World Rank

#868

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Philippe R. Marteau Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Philippe R. Marteau's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients (2008) (3557)
Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach (2005) (2083)
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target (2015) (1329)
Low counts of Faecalibacterium prausnitzii in colitis microbiota (2009) (1120)
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. (2007) (1076)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. (2010) (883)
Demonstration of safety of probiotics -- a review. (1998) (863)
Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon (2003) (742)
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management (2006) (656)
Protection from gastrointestinal diseases with the use of probiotics. (2001) (637)
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. (2000) (609)
European evidence-based Consensus on the management of ulcerative colitis: Current management. (2008) (593)
Safety of probiotics that contain lactobacilli or bifidobacteria. (2003) (547)
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial (2012) (483)
Specificities of the fecal microbiota in inflammatory bowel disease (2006) (421)
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial (2005) (409)
Comparative Study of Bacterial Groups within the Human Cecal and Fecal Microbiota (2001) (391)
Reliability and initial validation of the ulcerative colitis endoscopic index of severity. (2013) (332)
Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study (2005) (331)
European evidence based consensus on surgery for ulcerative colitis. (2015) (289)
Biodiversity of the Mucosa‐Associated Microbiota Is Stable Along the Distal Digestive Tract in Healthy Individuals and Patients With Ibd (2005) (277)
Bifidobacterium animalis strain DN‐173 010 shortens the colonic transit time in healthy women: a double‐blind, randomized, controlled study (2002) (266)
Highlighting new phylogenetic specificities of Crohn's disease microbiota (2011) (247)
Probiotics and prebiotics: effects on diarrhea. (2007) (238)
On the safety of lactic acid bacteria from food. (1995) (204)
Dysbiosis in inflammatory bowel disease: a role for bacteriophages? (2008) (199)
Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects. (2003) (182)
Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine (2007) (182)
Probiotics and intestinal health effects: a clinical perspective (2002) (173)
Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease (2006) (166)
Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study (2009) (165)
Calcium, phosphorus, vitamin D, dairy products and colorectal carcinogenesis: a French case--control study. (1996) (162)
Small Bowel Adenocarcinoma in Patients with Crohn's Disease Compared with Small Bowel Adenocarcinoma De Novo (2005) (159)
Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol (2012) (155)
Molecular inventory of faecal microflora in patients with Crohn's disease. (2003) (151)
Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study (2020) (149)
Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study (2020) (149)
Temperature Gradient Gel Electrophoresis of Fecal 16S rRNA Reveals Active Escherichia coli in the Microbiota of Patients with Ulcerative Colitis (2006) (144)
Saccharomyces boulardii does not prevent relapse of Crohn's disease. (2013) (143)
A neural network algorithm for detection of GI angiectasia during small-bowel capsule endoscopy. (2019) (142)
The efficacy and safety of a third anti‐TNF monoclonal antibody in Crohn’s disease after failure of two other anti‐TNF antibodies (2010) (128)
Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy? (2017) (127)
IOIBD technical review on endoscopic indices for Crohn's disease clinical trials (2015) (126)
Postoperative Complications after Ileocecal Resection in Crohn’s Disease: A Prospective Study From the REMIND Group (2017) (123)
One‐year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study (2017) (121)
Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease. (2016) (120)
Probiotics: Towards demonstrating efficacy (1999) (118)
Current level of consensus on probiotic science-Report of an expert meeting- London, 23 November 2009 (2010) (117)
Infliximab for refractory ulcerative colitis or indeterminate colitis: an open‐label multicentre study (2003) (113)
Distal intestinal obstruction syndrome in adults with cystic fibrosis. (2004) (110)
Intraoperative enteroscopy for diagnosis and management of unexplained gastrointestinal bleeding. (2000) (108)
Predictive Factors of Response to Cyclosporine in Steroid-Refractory Ulcerative Colitis (2008) (108)
Probiotics in clinical conditions (2002) (108)
Lactose Intolerance (2000) (107)
Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study (2016) (106)
Optimising monitoring in the management of Crohn's disease: a physician's perspective. (2013) (104)
Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgery (2015) (103)
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab (2017) (102)
Inability of Lactobacillus casei strain GG, L. acidophilus, and Bifidobacterium bifidum to degrade intestinal mucus glycoproteins. (1995) (101)
Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease. (2013) (101)
Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease (2009) (100)
Factors associated with diagnosis of obscure gastrointestinal bleeding by video capsule enteroscopy. (2012) (100)
Gut flora and inflammatory bowel disease (2004) (98)
Probiotic strain Bacillus subtilis CU1 stimulates immune system of elderly during common infectious disease period: a randomized, double-blind placebo-controlled study (2015) (95)
Tolerance to low-digestible carbohydrates: symptomatology and methods. (2001) (95)
Crohn's disease of the vulva. (2014) (92)
Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus (2017) (91)
Survival of Lactobacillus casei in the Human Digestive Tract after Consumption of Fermented Milk (2006) (91)
Review article: gut flora and inflammatory bowel disease. (2004) (88)
Search for Localized Dysbiosis in Crohn's Disease Ulcerations by Temporal Temperature Gradient Gel Electrophoresis of 16S rRNA (2005) (88)
A randomized double blind placebo controlled multicenter study of mesalazine for the prevention of acute radiation enteritis. (1997) (85)
Clinical Evidence for Immunomodulatory Effects of Probiotic Bacteria (2009) (84)
Impact of vedolizumab therapy on extra‐intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV‐IBD cohort (2018) (84)
Effects of chicory inulin in constipated elderly people: a double-blind controlled trial (2011) (83)
Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn’s disease (2009) (80)
Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX® 9 mg extended-release tablets in patients with active left-sided ulcerative colitis. (2010) (78)
Increased incidence of systemic serious viral infections in patients with inflammatory bowel disease associates with active disease and use of thiopurines (2020) (78)
Risk Factors Associated With Small Bowel Adenocarcinoma in Crohn's Disease: A Case–Control Study (2008) (77)
Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine (2003) (77)
Factors associated with pregnancy outcome in anti‐TNF treated women with inflammatory bowel disease (2014) (76)
Adverse events in patients treated with 5‐aminosalicyclic acid: 1993–1994 pharmacovigilance report for Pentasa in France (1996) (75)
Nutritional advantages of probiotics and prebiotics. (2002) (73)
Obscure gastrointestinal bleeding: preliminary comparison of 64-section CT enteroclysis with video capsule endoscopy (2010) (71)
Safety aspects of probiotic products (2001) (71)
S1107 Plexitis As Predictive Factor of Early Postoperative Clinical Recurrence in Crohn's Disease (2009) (70)
Effects of a 3-mo Consumption of Short-Chain Fructo-Oligosaccharides on Parameters of Colorectal Carcinogenesis in Patients With or Without Small or Large Colorectal Adenomas (2005) (69)
High Risk of Anal and Rectal Cancer in Patients With Anal and/or Perianal Crohn’s Disease (2017) (68)
Cellular and physiological effects of probiotics and prebiotics. (2004) (68)
Bacterial Flora in Inflammatory Bowel Disease (2010) (67)
Tolerance of probiotics and prebiotics. (2004) (65)
Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: rapid symptom resolution and improvements in quality of life. (2014) (63)
Patchy distribution of mucosal lesions in ileal Crohn's disease is not linked to differences in the dominant mucosa‐associated bacteria: A study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis (2007) (62)
Cyclosporine treatment of steroid‐refractory ulcerative colitis during pregnancy (2009) (61)
Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn’s Disease in Sustained Remission (2017) (59)
Manipulation of the bacterial flora in inflammatory bowel disease. (2003) (59)
Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort (2011) (57)
Malnutrition in adults with cystic fibrosis (2005) (57)
Radiofrequency ablation for the treatment of gastric antral vascular ectasia (2014) (55)
Treatment of gastrointestinal angiodysplasia and unmet needs. (2011) (52)
Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial (GA2LEN Study) (2014) (52)
Imaging of malignant neoplasms of the mesenteric small bowel: new trends and perspectives. (2011) (51)
Male gender, active smoking and previous intestinal resection are risk factors for post‐operative endoscopic recurrence in Crohn's disease: results from a prospective cohort study (2018) (50)
Probiotics and health: new facts and ideas. (2002) (49)
Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID Cohort. (2016) (49)
Surgical treatment of anoperineal Crohn's disease: can abdominoperineal resection be predicted? (1999) (47)
The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS] (2015) (47)
Molecular comparison of dominant microbiota associated with injured versus healthy mucosa in ulcerative colitis (2006) (47)
Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases (2018) (46)
A Randomised Controlled Trial of a Probiotic Lactobacillus Strain in Healthy Adults: Assessment of its Delivery, Transit and Influence on Microbial Flora and Enteric Immunity (2002) (46)
Probiotics, prebiotics, synbiotics: ecological treatment for inflammatory bowel disease? (2006) (44)
Cyclosporin Versus Infliximab in Severe Acute Ulcerative Colitis Refractory to Intravenous Steroids: A Randomized Trial (2011) (44)
Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease? (2008) (43)
Three‐year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi‐centre cohort study (2019) (40)
Interobserver Variation Study of the Rutgeerts Score to Assess Endoscopic Recurrence after Surgery for Crohn's Disease. (2016) (39)
A randomized, double‐blind, controlled study and pooled analysis of two identical trials of fermented milk containing probiotic Bifidobacterium lactis CNCM I‐2494 in healthy women reporting minor digestive symptoms (2013) (39)
Management and endoscopic techniques for digestive foreign body and food bolus impaction. (2013) (38)
Nomenclature and semantic description of vascular lesions in small bowel capsule endoscopy: an international Delphi consensus statement * (2019) (37)
Multidrug resistance gene‐1 polymorphisms and resistance to cyclosporine a in patients with steroid resistant ulcerative colitis (2007) (37)
Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease (2016) (37)
Portomesenteric Vein Thrombosis in Patients With Inflammatory Bowel Disease (2013) (35)
Diagnostic impact of routine colonoscopy following acute diverticulitis: A multicenter study in 808 patients and controls (2014) (35)
Inter-kingdom effect on epithelial cells of the N-Acyl homoserine lactone 3-oxo-C12:2, a major quorum-sensing molecule from gut microbiota (2018) (35)
CAD-CAP: a 25,000-image database serving the development of artificial intelligence for capsule endoscopy (2020) (33)
[Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate]. (2002) (32)
Accuracy of imaging for predicting operative approach in Crohn's disease (2012) (30)
Butyrate-producing bacteria as pharmabiotics for inflammatory bowel disease (2013) (30)
Radiofrequency ablation for the treatment of radiation proctitis (2014) (29)
Probiotics and Prebiotics : Effects on Diarrhea 1 , 2 (2007) (29)
Sexual health and fertility for individuals with inflammatory bowel disease (2019) (29)
Bacteria as Trigger for Chronic Gastrointestinal Disorders (2011) (28)
NOMENCLATURE AND SEMANTIC DESCRIPTIONS OF ULCERATIVE AND INFLAMMATORY LESIONS SEEN IN CROHN’S DISEASE IN SMALL BOWEL CAPSULE ENDOSCOPY: AN INTERNATIONAL DELPHI CONSENSUS STATEMENT (2020) (28)
Tolerance of 4-aminosalicylic acid enemas in patients with inflammatory bowel disease and 5-aminosalicylic-induced acute pancreatitis. (2004) (27)
Efficacy and tolerance of mesalazine suppositories vs. hydrocortisone foam in proctitis (1997) (26)
Targeting the Microbiome in Inflammatory Bowel Disease: Critical Evaluation of Current Concepts and Moving to New Horizons (2015) (26)
The Survival of and Cytokine Induction by Lactic Acid Bacteria after Passage Through a Gastrointestinal Model (1999) (26)
Modulation of Lactobacillus casei in ileal and fecal samples from healthy volunteers after consumption of a fermented milk containing Lactobacillus casei DN-114 001Rif. (2008) (25)
Efficacy of infliximab in Crohn's disease. Results of a retrospective multicenter study with a 15-month follow-up. (2006) (25)
Quality of Life Improvements Attributed to Combination Therapy with Oral and Topical Mesalazine in Mild-to-Moderately Active Ulcerative Colitis (2009) (24)
Long-term Outcomes of Thalidomide Therapy for Adults With Refractory Crohn's Disease. (2016) (23)
A comparison of physician-rated disease severity and patient reported outcomes in mild to moderately active ulcerative colitis. (2010) (23)
Living Drugs for Gastrointestinal Diseases: The Case for Probiotics (2006) (23)
Colorectal cancer in inflammatory bowel diseases: CT features with pathological correlation (2013) (22)
Fecal Primary Bile Acids and Serum Cholesterol Are Associated with Colorectal Adenomas (2003) (22)
Probiotics in functional intestinal disorders and IBS: proof of action and dissecting the multiple mechanisms (2010) (22)
Over-expression of colonic K+ channels associated with severe potassium secretory diarrhoea after haemorrhagic shock. (2008) (22)
Towards a multimodal wireless video capsule for detection of colonic polyps as prevention of colorectal cancer (2013) (21)
Comparative, open, randomized trial of the efficacy and tolerance of slow- release 5-ASA suppositories once daily versus conventional 5-ASA suppositories twice daily in the treatment of active cryptogenic proctitis (2000) (21)
Association Between Microscopic Lesions at Ileal Resection Margin and Recurrence After Surgery in Patients With Crohn's Disease. (2019) (20)
Crypt abscess-associated microbiota in inflammatory bowel disease and acute self-limited colitis. (2010) (19)
Emerging indications of endoscopic radiofrequency ablation (2015) (19)
Crohn’s disease: multi-detector row CT-enteroclysis appearance of the appendix (2010) (17)
Anti-TNF Therapy and Pregnancy in Inflammatory Bowel Disease: A Prospective Cohort Study From the GETAID (2011) (17)
[Anoperineal manifestations of Crohn's disease]. (2000) (15)
Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors? (2009) (15)
Discussion on genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. (2003) (15)
829 Long-Term Outcomes in a Cohort of Patients With Acute Severe Ulcerative Colitis Refractory to Intravenous Steroids Treated With Cyclosporine or Infliximab (2015) (14)
Immunological Effects of Biotherapeutic Agents (1999) (14)
Development and validation of an automated algorithm to evaluate the abundance of bubbles in small bowel capsule endoscopy (2018) (13)
Ulcerative Colitis and Electronic Cigarette: What's the Matter? (2014) (13)
A Scoring System to Determine Patients' Risk of Colectomy Within 1 y After Hospital Admission for Acute Severe Ulcerative Colitis. (2020) (13)
Intestinal microbiota in health and disease (2015) (13)
Mesalazine-induced lupus. (1997) (13)
Best practice in the management of mild-to-moderately active ulcerative colitis and achieving maintenance of remission using mesalazine (2010) (13)
Development and validation of a computed assessment of cleansing score for evaluation of quality of small-bowel visualization in capsule endoscopy (2018) (12)
Development of a computed cleansing score to assess quality of bowel preparation in colon capsule endoscopy (2016) (12)
Extra-intestinal malignancies in inflammatory bowel diseases: An update with emphasis on MDCT and MR imaging features. (2015) (11)
DOP025 Efficacy of vedolizumab on extraintestinal manifestation in patients with inflammatory bowel disease: a post-hoc analysis of the OBSERV-IBD cohort from the GETAID. (2017) (11)
Anti-TNFα therapy early improves hemodynamics in local intestinal and extraintestinal circulations in active Crohn's disease. (2013) (11)
An economic evaluation comparing concomitant oral and topical mesalazine versus oral mesalazine alone in mild-to-moderately active ulcerative colitis based on results from randomised controlled trial. (2009) (10)
A guide for assessing the clinical relevance of findings in small bowel capsule endoscopy: analysis of 8064 answers of international experts to an illustrated script questionnaire. (2021) (10)
Evidence of Probiotic Strain Specificity Makes Extrapolation of Results Impossible From a Strain to Another , Even From the Same Species (2011) (10)
[MR imaging of ano-perineal suppurations]. (2003) (10)
Risk of serious infection in healthcare workers with inflammatory bowel disease: a case‐control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID) (2018) (9)
Efficacy of Vedolizumab on Extraintestinal Manifestation in Patients with Inflammatory Bowel Diseases: A Post-Hoc Analysis of the Observ-IBD Cohort of the Getaid (2017) (9)
Pure ileal Crohn's disease without colonic involvement after a long ileo-colonic anastomosis (Lester Martin Procedure) for Hirschsprung's disease: an argument favoring a specific sensitivity of the ileum in a subset of patients with Crohn's disease. (2007) (9)
Probiotics and the Intestinal Microflora: What Impact on the Immune System, Infections and Aging? (2006) (9)
Dose raising of azathioprine beyond 2.5 MG/KG/day in Crohn's disease patients who fail to improve with a standard dose (1998) (9)
Pharmacokinetics and safety of fidaxomicin in patients with inflammatory bowel disease and Clostridium difficile infection: an open-label Phase IIIb/IV study (PROFILE) (2018) (9)
Evolution of endoscopic lesions in steroid-refractory acute severe ulcerative colitis responding to infliximab or cyclosporine. (2020) (8)
Rectal cancer in inflammatory bowel diseases: MR imaging findings (2014) (8)
Inflammatory bowel disease: what is new? (2004) (8)
Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer (2022) (8)
Elaboration and validation of Crohn’s disease anoperineal lesions consensual definitions (2017) (7)
Costs of Crohn's Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 Years (2016) (7)
[Comparative randomized open study of the efficacy and tolerance of enemas with 2 gr of 4-amino-salicylic acid (4-ASA) and 1 gr of 5-amino-salicylic acid (5-ASA) in distal forms of hemorrhagic rectocolitis]. (1995) (7)
313 Long-Term Outcome After Infliximab Withdrawal for Sustained Remission in Crohn's Disease (2016) (7)
Inflammatory bowel disease. (2000) (6)
α-chain disease: Analysis of α-chain protein and secretory component in jejunal fluid (1993) (6)
1096 Are Random Biopsies Still Useful for the Detection of Intraepithelial Neoplasia in IBD Patients Undergoing Surveillance Colonoscopy With Chromoendoscopy (2012) (6)
[Digestive and nutritional management of adults with cystic fibrosis]. (2000) (6)
No-incision (NOTES) versus single-incision (single-port) surgery for access to sites of peritoneal carcinomatosis: a back-to-back animal study (2012) (6)
Corrigendum to “European-evidence-based consensus on the management of ulcerative colitis: Current management” [J Crohns & Colitis 2 (2008) 24–62] (2008) (6)
Mo1385 Diagnostic and Therapeutic Impacts of Elective Colonoscopy Following Acute Sigmoid Diverticulitis (2012) (6)
[Introduction of the evidence]. (2004) (6)
Su1229 Definitions of the Endoscopic Lesions in Crohn's Disease: Reproductibility Study and GETAID Expert Consensus (2015) (6)
1040 Radiofrequency Ablation Treatment of Gastric Antral Vascular Ectasia: Results From an International Collaborative Study (2013) (6)
Decrease in factor V activity: a new adverse effect of purine analogs in inflammatory bowel diseases? (2008) (5)
Bacteremia in patients receiving TNF-alpha antagonists--a prospective multicenter study. (2013) (5)
Bleeding from gastroduodenal metastases as the first manifestation of lung adenocarcinoma (2014) (5)
Prebiotic carbohydrates: not sweet yet for Crohn's disease? (2011) (5)
The Microbiota in Infl ammatory Bowel Disease (2014) (5)
Azathioprine (AZA) for ulcerative coltis: A retrospective multicente study on 131 patients (2001) (5)
Endoscopy as a Prognostic Marker in Inflammatory Bowel Disease (2013) (4)
[The clinical importance of intestinal microbiota]. (2010) (4)
Short-term digestive tolerance of high-dose of NUTRIOSE®FB10 in adult (2011) (4)
Effect of bifidobacterium fermented milk (Bio strain) on the colonic transit time in healthy humans (1995) (4)
Octreotide for recurrent intestinal variceal bleeding in patients without portal hypertension. (2009) (4)
REAL LIFE EXPERIENCE WITH THE USE OF A HEMOSTATIC POWDER IN 152 PATIENTS UNDERGOING URGENT ENDOSCOPY FOR GASTROINTESTINAL BLEEDING (2020) (4)
Proceedings of Réanimation 2017, the French Intensive Care Society International Congress (2017) (4)
1049 Identification of Items to Be Included in An Ulcerative Colitis Endoscopic Index of Severity (UCEIS) (2009) (4)
P772 The presence of adherent-invasive Escherichia coli strains on the surgical specimen is a predictor of severe endoscopic postoperative recurrence in Crohn's disease. (2017) (4)
[Management of ileal stenosis in patients with Crohn's disease]. (2009) (3)
141 Pregnancy Outcome in Inflammatory Bowel Disease for Women Treated with Thiopurine: Cohort from the CESAME Study (2009) (3)
Defining and assessing the reproducibility of Crohn's disease endoscopic lesions: a Delphi-like method from the GETAID. (2020) (3)
[Recommendations for clinical practice for the treatment of ulcerative colitis]. (2004) (3)
[Inflammatory bowel disease and pregnancy]. (2003) (3)
Sa1028 TERMINOLOGY AND DESCRIPTION OF VASCULAR LESIONS IN SMALL BOWEL CAPSULE ENDOSCOPY: AN INTERNATIONAL DELPHI CONSENSUS STATEMENT (2018) (3)
P390 Open-label study to evaluate the pharmacokinetics of fidaxomicin in inflammatory bowel disease patients with Clostridium difficile infection (the PROFILE study): pharmacokinetics analysis. (2017) (3)
Alpha-chain disease: analysis of alpha-chain protein and secretory component in jejunal fluid. (1993) (3)
Transgastric NOTES for the detection of peritoneal carcinomatosis: more targets needed for a thorough evaluation. (2010) (3)
Nodular regenerative hyperplasia with portal hypertension in patients with inflammatory bowel disease treated with azathioprine (2006) (3)
Towards embedded detection of polyps in videocolonoscopy and WCE images for early diagnosis of colorectal cancer (2013) (3)
Role of antibiotics and probiotics in the management of inflammatory bowel disease (2003) (3)
[Digestive complications in adults with cystic fibrosis]. (2005) (2)
Molecular study of the ileal and colonic mucosa associated flora in IBD (2003) (2)
Upper gastrointestinal bleeding from Brunner's gland hamartoma. (2011) (2)
P043 BUDESONIDE MMX IS EFFICIENT AND SAFE IN PATIENTS WITH ACTIVE LEFT-SIDED ULCERATIVE COLITIS (2007) (2)
The Microbiome in IBD (2019) (2)
Gut microbiota : a full-fledged organ / coordinated by Philippe Marteau and Joël Doré (2017) (2)
Mo1896 The Real-Life Experience of Vedolizumab Efficacy and Safety in Crohn's Disease: A Prospective Observational Multicenter Cohort Study (2016) (2)
Interactions of the Intestinal Microbiota with Mucosal Epithelial Cells (2014) (2)
Differences, in human, between the bacterial communities of the cecum and the feces: a study using direct analysis of 16S rRNA genes (2003) (2)
P300 Counterbalancing Dysbiosis in Crohn's Disease: Faecalibacterium Prausnitzii, a Major Commensal Bacterium, Exhibits in Vitro and in Vivo Anti-Inflammatory Effects (2008) (2)
Mo1619 Radiofrequency Ablation Treatment of Radiation Proctitis: Results From an European Collaborative Study (2013) (2)
Mo1687 Efficacy of Anti-TNF on Severe Postoperative Endoscopic Recurrence in Crohn's Disease (2012) (2)
683 Postoperative Complications After Ileo-Caecal Resection for Crohn's Disease: A Prospective Multicentre Study (2015) (2)
Safety of high doses of mesalazine during pregnancy. (2005) (2)
Evaluation of disease extent with the Crohn's disease endoscopic index of severity (2013) (2)
Is there any need for video capsule endoscopy evaluation in postduodenal small-bowel polyps detection in familial adenomatous polyposis? (2007) (2)
IBD and pregnancy. (2008) (2)
[Role of prebiotics and probiotics in therapeutic management of cryptogenetic inflammatory bowel disease]. (2001) (2)
[Malnutrition and low bone mineralisation in adults with cystic fibrosis]. (2006) (2)
403 A HIGHLY SENSITIVE AND HIGHLY SPECIFIC CONVOLUTIONAL NEURAL NETWORK-BASED ALGORITHM FOR AUTOMATED DIAGNOSIS OF ANGIODYSPLASIA IN SMALL BOWEL CAPSULE ENDOSCOPY (2018) (2)
Development and Validation of a Highly Sensitive and Highly Specific Computed Assessment of Cleansing Score for Small Bowel Capsule Endoscopy (2016) (2)
S1161 Quality of Life (Health-Related Utility) in Adults with Ulcerative Colitis in Remission vs. Mild/Moderate and Severe Relapse: Findings from the Podium Study (2009) (2)
Case of prednisolone-induced hepatitis in a patient with ulcerative colitis. (2013) (2)
510 Single-Incision Flexible Endoscopic Peritoneoscopy for Staging of Peritoneal Carcinomatosis: High Diagnostic and Therapeutic Impact (2012) (2)
[Colobiliary fistula with a liver abscess complicating adenocarcinoma of the ascending colon]. (2007) (1)
Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study (2022) (1)
Molecular analysis of the fecal flora of patients with inactive colonic crohn's disease (2001) (1)
FRI0167 Alopecia areata occuring during tnf blockers therapy : a french multicentric survey (2013) (1)
The Presence of Adherent-Invasive Escherichia Coli (AIEC) on the Surgical Specimen is a Predictor of Severe Endoscopic Postoperative Recurrence in Ileal Crohn's Disease (2017) (1)
In vivo effect of proton-pump inhibitors on gastric plasmin-dependent fibrinolysis: a study in a porcine model. (2012) (1)
[Practical forms for the use of the main drugs in the treatment of ulcerative colitis]. (2004) (1)
T2027 Lactobacillus casei Dn-114 Oo1 Strain in the Prevention of Postoperative Recurrence of Crohn's Disease: A Randomised, Double-Blind Placebo-Controlled Trial (2010) (1)
Clinical and pathological aspects of inflammatory bowel disease. (1999) (1)
Introduction (2014) (1)
Sa1743 Development of a Computed Cleansing Score to Assess the Quality of Bowel Preparation in Colon Capsule Endoscopy (2017) (1)
891i: No Incision (NOTES®) vs Single Incision (SILS) Surgery for Access to Elective Sites of Peritoneal Carcinomatosis: Back-to-Back Comparison in a Live Porcine Model (2010) (1)
[Probiotics in inflammatory bowel disease: controlled trials and perspectives]. (2004) (1)
Correction of Microbiota Disturbances or Antagonism Against Specific Pathogens in IBD (2014) (1)
Presentation of Microbial Signals via Maternal Cells: An Evolutionary Advantage of Mammals (2014) (1)
M1502: Single Port Peritoneoscopy: Be Flexible! Results of a Randomized Controlled Trial in a Live Porcine Model Translated to Human Cadavers (2010) (1)
Radiofrequency ablation for the treatment of radiation (2014) (1)
[Crohn's disease: nutrition should not be forgotten]. (2006) (1)
Manipulation of the Host-Cell Pathways by Bacterial Enteropathogens (2014) (1)
Su1585 Single-Incision Laparoscopic Evaluation of Peritoneal Carcinomatosis: First Human Cases With Combined Flexible Endoscopy (2011) (1)
Mycophenolate mofetil (MMF) in refractory Crohn's disease after failure of treatments by azathioprine (AZA) or methotrexate (MTX) (2008) (1)
Tu1403 A Live Porcine Model of Bleeding Ulcer (2011) (1)
[Acute diarrhoea in the adult (with treatment)]. (2006) (1)
Anti-TNF for Post-Operative Prevention in Crohn's Disease: The Detection of Anti-Drug Antibodies at Time of Surgery is Associated with an Increased Risk of Endoscopic Recurrence (2017) (1)
Evaluation by a Machine Learning System of Two Preparations for Small Bowel Capsule Endoscopy: The BUBS (Burst Unpleasant Bubbles with Simethicone) Study (2022) (1)
P071 Risk Factors Associated With Small Bowel Adenocarcinoma in Crohn's Disease: A Case-Control Study (2007) (1)
Infl uence of the Intestinal Microbiota on the Critically (2014) (1)
Diagnostic criteria for inflammatory bowel disease in adults. (1999) (1)
Subject Index Vol. 33, Suppl. 1, 2015 (2015) (0)
Cases and Techniques Library ( CTL ) E 474 (2014) (0)
[Anoperineal lesions in Crohn's disease: Still frequent despite anti-TNF agents]. (2019) (0)
Iconographies supplémentaires de l'article : Gastroentéropathies exsudatives (2015) (0)
28 Role of antibiotics and probiotics in the management of inflammatory bowel disease (0)
Altered secretion in the right colon during ulcerative colitis: is it due to disease or to 5‐ASA? (2013) (0)
W1222 Cyclosporine a Treatment of Severe Steroid-Refractory Ulcerative Colitis During Pregnancy (2008) (0)
Pathogen-Host Cell Interactions at the Intestinal Level: Lessons from Cultured Human Fully-Differentiated Colon Cancer Caco-2 and T84 Epithelial Cell Lines (2014) (0)
P364 Efficacy of anti-TNF on severe postoperative endoscopic recurrence in Crohn's disease (2012) (0)
mechanisms IBS: proof of action and dissecting the multiple Probiotics in functional intestinal disorders and (2010) (0)
Corrigendum to ‘Optimising monitoring in the management of Crohn's disease: A physician perspective’ [Journal of Crohn's and Colitis volume 7 (2013) 653–669] (2014) (0)
Sa1949 A Negative Screening Does Not Eliminate Tuberculosis Risk Under Anti-TNF Treatment in Inflammatory Bowel Disease: A Descriptive Study (2016) (0)
Inflammatory bowel disease. (2002) (0)
Abstracts of the 2007 Conference on Gastrointestinal Function. Chicago, Illinois, USA. April 16–18th, 2007-01-30 (2007) (0)
Iconographies supplémentaires de l'article : Extra-intestinal malignancies in inflammatory bowel diseases: An update with emphasis on MDCT and MR imaging features (2015) (0)
C-reactive protein values after surgery for inflammatory bowel disease: is it still a good marker for intra-abdominal complication? A retrospective cohort study of 347 procedures (2022) (0)
Small bowel adenocarcinoma (SBA) with and without Crohn disease (CD) (2003) (0)
PMD4 PERCEPTION OF IRON DEFICIENCY IN CLINICAL PRACTICES: MULTIDISCIPLINARY FRENCH SURVEY (SUPFER SURVEY) (2011) (0)
[Recommendations for clinical practice for the treatment of ulcerative colitis: general method]. (2004) (0)
Su1794 Proton-Pump Inhibitors Have No Significant Effect on Gastric Plasmin-Dependent Fibrinolysis in a Live Porcine Model (2012) (0)
Selection of a probiotic strain to modify human gut flora and a controlled trial of delivery and efficacy (1998) (0)
P199 Hidradenitis suppurativa associated with Crohn’s disease: An increased risk of permanent stoma (2018) (0)
Bacterial Flora: Epidemiology and Geographical Variation (2006) (0)
[Refractory proctitis]. (2007) (0)
Recent advances and emerging therapies in the non-surgical (2018) (0)
A randomized trial comparing the efficacy and tolerance of classical and slow release 5-ASA suppositories to treat acute attacks of ulcerative proctitis (1998) (0)
Online training on how to diagnose anoperineal lesions of Crohn's disease: Do pictures matter? A nationwide randomized study. (2019) (0)
P 770 First analysis from UK IBD Twin Biobank ; 16 S rRNA gene sequencing identifies reduced diversity in IBD and bacterial taxa associated with disease (0)
T1238 Fecal Microbiota Alterations in Inflammatory Bowel Disease (IBD): Decrease of Faecalibacterium Prausnitzii But No Quantitative Variation of Escherichia coli (2008) (0)
Arbres décisionnels de l'article : Gastroentéropathies exsudatives (2015) (0)
Probiotics in Infl ammatory Bowel Disease: Modulation of (2014) (0)
A probiotic-vitamin combination to protect against common cold? (2005) (0)
We acknowledge patients and their families, and thank family recruitment doctors: (2001) (0)
P711 The real-life experience of vedolizumab therapy in the OBSERV-IBD cohort: a 3-year prospective observational multi-centre cohort study (2019) (0)
Autoévaluations de l'article : Gastroentéropathies exsudatives (2015) (0)
OP-JANM180369 1..12 (2018) (0)
Effects of native chicory inulin on constipation in elderly people. (2010) (0)
[Combination of purine analogues and aminosalicylates in patients with inflammatory bowel disease: why and how?]. (2007) (0)
Development and Validation of a Highly Sensitive and Specific Automated Algorithm to Evaluate the Abundance of Bubbles in Small Bowel Capsule Endoscopy (2017) (0)
of genetically altered mice Use of echocardiography for the phenotypic assessment (2015) (0)
Oral/Rectal or Combination 5-Aminosalicylic Acid? (2011) (0)
Probiotic strain Bacillus subtilis CU1 stimulates immune system of elderly during common infectious disease period: a randomized, double-blind placebo-controlled study (2015) (0)
Inflammatory bowel disease. A clinicians'guide (2008) (0)
Inflammatory bowel diseases: from bench to bedside. Second edition (2008) (0)
Probiotics for inflammatory bowel disease (2006) (0)
T1263 Serrated Polyps in Patients With Inflammatory Bowel Disease (2010) (0)
Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study (2020) (0)
Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study (2020) (0)
Intestinal Alpha-chain Protein and Secretory Component (sc) in Alpha-chain Disease (alpha-cd) (1992) (0)
disease revealed by a metagenomic approach Reduced diversity of faecal microbiota in Crohn's (2009) (0)
Immediate Duodenal Delevery, vs Delayed Oral Ingestion, of Capsule Endoscopy: is the Sooner the Better? A Prospective Comparison of Small Bowel Visualization Quality, According to a Computed Assessment of Cleansing Score. (2016) (0)
[Crohn's disease and ulcerative colitis]. (2007) (0)
P420 Anti-TNF for post-operative prevention in Crohn's disease: the detection of anti-drug antibodies at time of surgery is associated with an increased risk of endoscopic recurrence. (2017) (0)
Mild to moderate ulcerative colitis: sequential and combined treatments (2009) (0)
Corrigendum: Ulcerative Colitis and Electronic Cigarette: What's the Matter? (2014) (0)
Treatment of Crohn's disease by infliximab: Long term efficiency in 137 patients treated during the year 2000 (2003) (0)
Introduction de l’argumentaire (2004) (0)
T1310 Almost One Half of Inflammatory Bowel Disease (IBD) Patients at High Risk of Colorectal Neoplasia Do Not Undergo Endoscopic Surveillance: A Clinical Practice Study Nested in the CESAME Cohort (2010) (0)
Concise Commentary: Second Line Is Not Second Best—Continuing Validity of the Oxford Criteria in the Management of Acute Severe Ulcerative Colitis (2019) (0)
Novel Therapies for IBD (2015) (0)
Portal Vein Thrombosis in Inflammatory Bowel Disease (IBD) Patients: Analysis of a Retrospective Cohort of the GETAID (2011) (0)
DOP011 Risk of opportunistic infection in healthcare personnel with inflammatory bowel disease: a case-control study of the GETAID. (2017) (0)
Biodiversity in the fecal flora of patients with active and inactive IBD: Molecular assessment with temporal temperature gradient gel electrophoresis (2001) (0)
The Tissue Effect of Argon Plasma Coagulation on Human Gastric Mucosa : Ex Vivo Study (2016) (0)
Proctitis: what doctors should know and do (2016) (0)
Informations au patient de l'article : Gastroentéropathies exsudatives (2015) (0)
Digestive Diseases. Introduction. (2014) (0)
Sa1161 Predictors of Post-Operative Endoscopic Recurrence in Crohn's Disease: A Multicenter Prospective Study (2015) (0)
Probiotics and health : new facts and ideas Marteau (0)
Dysphagia in a patient with recurrent bilateral eyelid ptosis. (2010) (0)
IBD 2014: Thinking Out of the Box: Falk Symposium 192, Paris, May 2014 (2014) (0)
1121 Autoimmune Pancreatitis Associated With Inflammatory Bowel Disease: A Multicentric Study of the GETAID (2016) (0)
Subject Index Vol. 32, Suppl. 1, 2014 (2014) (0)
[Inguinal lymphadenitis after rectal examination in a man with hemorroidal prolapsus]. (2004) (0)
Raied patients and controls Diagnostic impact of routine colonoscopy following acute diverticulitis : A multicenter study in 808 (2014) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Philippe R. Marteau?

Philippe R. Marteau is affiliated with the following schools:

Philippe R. Marteau's Academic­Influence.com Rankings

Why Is Philippe R. Marteau Influential?

Philippe R. Marteau's Published Works

Published Works

What Schools Are Affiliated With Philippe R. Marteau?

Philippe R. Marteau's AcademicInfluence.com Rankings